Nanotechnology in Medicine. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Nanotechnology in Medicine - Группа авторов страница 19

Nanotechnology in Medicine - Группа авторов

Скачать книгу

particle shape, aspect ratio, chemical composition, hydrophilicity and hydrophobicity, surface coating, surface roughness, aggregation and concentration, degradability 2. Biological behavior of nanomaterials Protein corona effects, metabolism, distribution, clearance mechanisms, toxicity against cells and tissues of the reticuloendothelial system, therapeutic efficacy, safety 3. Toxic effects of nanoparticles Renal toxicity, spermatotoxicity, hepatotoxicity, cardiovascular toxicity, dermal toxicity, neurotoxicity, pulmonary toxicity 4. Mechanisms of nanoparticle toxicity Oxidative stress, cell membrane damage, disturbance of intracellular/intercellular transport, accelerate mutagenesis, cell energy imbalance, apoptosis, hindered cell division, disruption of cell, tissue and organ metabolism Schematic illustration of consequences of environmental contact of nanoparticles.

      It has been reported that AuNPs possibly move through a mother's placenta to the fetus. During the neonatal phase, these NPs can act as allergens, activating the immune system. NPs can communicate with diverse immune cell networks found inside and under epithelial surfaces. The proficient gastrointestinal tract uptake of NPs also been well recorded in oral feeding and forced feeding studies. Despite the clinical approval, the dermal toxicity of nanosilver‐based surgical dressings and sutures is yet a matter of concern (El‐Ansary and Al‐Daihan 2009). While beneficial control of wound infection is accomplished, their dermal toxicity is even of concern. In epidemiological trials, adverse cardiovascular effects attributable to exposure to NPs have been identified (De Jong and Borm 2008). Oxidative damage to DNA is exhibited by the titanium dioxide and zinc oxide NPs in in vitro tests and cultured human fibroblasts. Nano‐sized particles inhaled can increase bloodstream access and can then be spread to other organs. There is a good likelihood that, via the lungs, skin, and gastrointestinal tract, NPs may be assimilated into the bloodstream. Besides, fluids representing the liver, blood, and airway environment are exploited to conduct experiments concerning the dissolution of NPs in artificial body fluids and classify harmful influences. NPs also have access to the brain, exhibiting toxic effects on BBB, especially high concentrations of anionic and cationic NPs, although, neutral NPs and low concentrations of anionic NPs were found not to affect the integrity of BBB (Teleanu et al. 2019). The development of reactive oxygen species and oxidative stress are caused by NPs. Further, these have shown to be involved in the development of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases (Armstead and Li 2016).

      The dominant role of protein–nanoparticle interactions has begun to appear in nanomedicine and nanotoxicity. The “corona” nanoparticle protein is a dynamic coating of proteins and other biomolecules that adsorbs to the surfaces of the nanoparticle (Dickinson et al. 2019). Protein corona is a nanoparticle's biological identity since it is what the cell “sees and communicates.” At any given time, the structure of the corona protein can be determined by the concentrations of over 3700 plasma proteins. When exposed to a biological fluid, this corona may not achieve equilibrium automatically. The nanoparticle surface would initially be dominated by proteins with high concentrations and elevated interaction rate constants. They can also easily dissociate to be swapped by reduced concentration, leisurely exchange, and greater affinity proteins. Small NPs may cause protein malfunction, with their wide surface area as a binding interface, which may lead to pathogenesis and adverse health effects (Sukhanova et al. 2018; Singh et al. 2019).

      The latest toxicological approaches utilized for the detection of NP hazards are based on conventional toxicology approaches or complementary techniques. These tools for safety assessment of the rapidly budding list of nanomaterials have innate restrictions. There is a rising demand for strategies that could be adopted for screening by industries during the advancement of nanoproducts. These products may have to be handled on a case‐by‐case basis and require costly evaluations. Usually, acute and chronic toxicity is assessed in the pharmaceutical industry. The acute toxicity incorporates mitochondrial activity hemolysis, oxidative stress, inflammation, or complement activation. The chronic toxicity investigation is arduous, and it is more perplexing to scrutinize the results (Zhao

Скачать книгу